Form 4 for BSX Boston Scientific
Accepted 2022-03-31 00:00:00 ET · period of report 2022-03-29 · accession 0001225208-22-005267 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-31 | 2022-03-29 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | M - OptEx | $16.31 | +5,411 | 40.5K | +15% | +$88.3K |
| D | 2022-03-31 | 2022-03-29 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | S - Sale+OE | $45.00 | -10.3K | 30.3K | -25% | -$462.1K |
| D | 2022-03-31 | 2022-03-29 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | M - OptEx | $0.00 | -5,411 | 10.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-29 | M | A | 5,411 | $16.31 | 40,547 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-29 | S | D | 10,269 | $45.00 | 30,278 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-29 | M | D | 5,411 | $0.00 | 10,822 | D | $16.31 · — to 2025-02-23 | 5,411 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |